The authors address the challenge of predicting drug–target interactions, which is crucial for drug repurposing, by introducing a robust benchmarking framework. Using a biologically driven strategy, they uncover previously unknown interactions.
- Jesus de la Fuente
- Guillermo Serrano
- Mikel Hernaez
